Novo Nordisk (NVO) is trading at $42.33, up 2.44% on the session, with price holding above its short- and medium-term moving averages. Binance futures data show stronger buying pressure, but the st...
Novo Nordisk (NVO) is firm at $42.33, with the 24-hour range stretching from $41.26 to $42.53 and volume on Binance futures running at $680,658. The move matters because price is still holding above the 7-day, 20-day, and 50-day simple moving averages, which keeps the near-term trend constructive rather than corrective.
The broader setup is not one-way, though. NVO is now trading just under the upper Bollinger Band at $42.42 and close to immediate resistance at $42.82, so momentum is strong but not unchallenged.
The moving-average stack is still bullish: SMA 7 at $41.26 sits above SMA 20 at $40.56, which sits above SMA 50 at $39.31. That alignment usually signals an intact uptrend, and the EMA readings at $41.07 and $40.48 reinforce that bias.
Momentum is less clean than the trend. RSI at 63.78 sits in neutral territory, while the MACD line and signal are both at 0.5924 with a flat histogram, which points to fading directional separation even as price stays elevated. Stochastic %K at 71.88 also shows the tape leaning toward the upper end of its recent range.
9766 puts NVO very near the upper band, which means upside extension is possible, but the stock is already pricing in a lot of near-term strength. 26 suggests enough daily volatility for a meaningful move in either direction.
Source link







